Accessibility settings

This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (450) HIV/AIDS/STI Prevention and Care (1086)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/52565, first published .
Sitafloxacin- Versus Moxifloxacin-Based Sequential Treatment for Mycoplasma Genitalium Infections: Protocol for a Multicenter, Open-Label Randomized Controlled Trial

Sitafloxacin- Versus Moxifloxacin-Based Sequential Treatment for Mycoplasma Genitalium Infections: Protocol for a Multicenter, Open-Label Randomized Controlled Trial

Sitafloxacin- Versus Moxifloxacin-Based Sequential Treatment for Mycoplasma Genitalium Infections: Protocol for a Multicenter, Open-Label Randomized Controlled Trial

Authors of this article:

Naokatsu Ando1 Author Orcid Image ;   Daisuke Mizushima1 Author Orcid Image ;   Yosuke Shimizu2 Author Orcid Image ;   Yukari Uemura2 Author Orcid Image ;   Misao Takano1 Author Orcid Image ;   Morika Mitobe3 Author Orcid Image ;   Kai Kobayashi3 Author Orcid Image ;   Hiroaki Kubota3 Author Orcid Image ;   Hirofumi Miyake3 Author Orcid Image ;   Jun Suzuki3 Author Orcid Image ;   Kenji Sadamasu3 Author Orcid Image ;   Takato Nakamoto1 Author Orcid Image ;   Takahiro Aoki1 Author Orcid Image ;   Koji Watanabe1 Author Orcid Image ;   Shinichi Oka1 Author Orcid Image ;   Hiroyuki Gatanaga1 Author Orcid Image
Article Authors Cited by (1) Tweetations (2) Metrics

Journals

  1. Waites K, Xiao L, Atkinson T, Geisler W. The Role of Antimicrobial Susceptibility and Resistance Testing for Mycoplasma genitalium in Clinical Care. Open Forum Infectious Diseases 2026;13(Supplement_2):S1367 View